-+ 0.00%
-+ 0.00%
-+ 0.00%

*Ovid Therapeutics: Eliseo Salinas Transitions From Consulting for Co to Permanent Role of Executive R&D Advisor to CEO >OVID

Dow Jones·07/08/2026 11:16:00

Please log in to view news